| Enzo |
ALX-162-030-MC05 |
Myelin oligodendrocyte glycoprotein (35-55) (mouse, rat)
|
0.5mg |
|
|
| Enzo |
ALX-162-017-M001 |
N-Myristoyl-Lys-Arg-Thr-Leu-Arg-OH
|
1mg |
|
|
| Enzo |
ALX-162-017-M005 |
N-Myristoyl-Lys-Arg-Thr-Leu-Arg-OH
|
5mg |
|
|
| Enzo |
ALX-162-013-M001 |
Myosin light chain kinase substrate
|
1mg |
|
|
| Enzo |
ALX-162-011-M001 |
Myosin light chain kinase (11-19) amide
|
1mg |
|
|
| Enzo |
ALX-162-009-M001 |
Myelin basic protein (bovine) (4-14)
|
1mg |
|
|
| Enzo |
ALX-162-009-M005 |
Myelin basic protein (bovine) (4-14)
|
5mg |
|
|
| Enzo |
ALX-162-007-M001 |
Melittin (synthetic)
|
1mg |
|
|
| Enzo |
ALX-162-007-MC05 |
Melittin (synthetic)
|
0.5mg |
|
|
| Enzo |
ALX-162-006-M001 |
Melittin (natural)
|
1mg |
|
|
| Enzo |
ALX-162-006-M005 |
Melittin (natural)
|
5mg |
|
|
| Enzo |
ALX-162-005-M001 |
MARCKS protein (bovine brain) (159-165) amide
|
1mg |
|
|
| Enzo |
ALX-162-004-MC05 |
MARCKS protein (bovine brain) (151-175)
|
0.5mg |
|
|
| Enzo |
ALX-162-004-M001 |
MARCKS protein (bovine brain) (151-175)
|
1mg |
|
|
| Enzo |
ALX-162-002-MC05 |
MCD peptide
|
0.5mg |
|
|
| Enzo |
ALX-158-011-MC05 |
Humanin (human)
|
0.5mg |
|
|
| Enzo |
ALX-158-011-M001 |
Humanin (human)
|
1mg |
|
|
| Enzo |
ALX-157-001-M250 |
L Glutathione (oxidized form)
|
250mg |
|
|
| Enzo |
ALX-157-002-G025 |
L Glutathione (reduced form)
|
25g |
|
|
| Enzo |
ALX-157-002-G005 |
L Glutathione (reduced form)
|
5g |
|
|
| Enzo |
ALX-158-003-M001 |
Histone H2B (29-35)
|
1mg |
|
|
| Enzo |
ALX-157-021-M001 |
Ghrelin (human)
|
1mg |
|
|
| Enzo |
ALX-157-022-M001 |
Ghrelin (rat)
|
1mg |
|
|
| Enzo |
ALX-157-022-MC05 |
Ghrelin (rat)
|
0.5mg |
|
|
| Enzo |
ALX-157-021-MC05 |
Ghrelin (human)
|
0.5mg |
|
|
| Enzo |
ALX-157-011-MC01 |
Guanylin (rat, mouse)
|
0.1mg |
|
|
| Enzo |
ALX-157-010-MC01 |
Guanylin (human)
|
0.1mg |
|
|
| Enzo |
ALX-157-003-PC05 |
Galanin (human)
|
0.5mg* |
|
|
| Enzo |
ALX-157-003-P001 |
Galanin (human)
|
1mg* |
|
|
| Enzo |
ALX-157-001-G005 |
L Glutathione (oxidized form)
|
5g |
|
|
| Enzo |
ALX-157-001-G001 |
L Glutathione (oxidized form)
|
1g |
|
|
| Enzo |
ALX-155-037-M001 |
Extracellular death factor
|
1mg |
|
|
| Enzo |
ALX-155-023-M001 |
EGF receptor (human) (652-657)
|
1mg |
|
|
| Enzo |
ALX-155-023-M005 |
EGF receptor (human) (652-657)
|
5mg |
|
|
| Enzo |
ALX-155-018-M001 |
ET B receptor antagonist [RES-701-1]
|
1mg |
|
|
| Enzo |
ALX-155-020-MC05 |
ET B receptor antagonist . sodium salt
|
0.5mg |
|
|
| Enzo |
ALX-155-022-M005 |
EGF receptor (human) (651-658) (N-Myristoylated)
|
5mg |
|
|
| Enzo |
ALX-155-022-M001 |
EGF receptor (human) (651-658) (N-Myristoylated)
|
1mg |
|
|
| Enzo |
ALX-155-021-M001 |
EGF receptor (human) (651-658)
|
1mg |
|
|
| Enzo |
ALX-155-020-M001 |
ET B receptor antagonist . sodium salt
|
1mg |
|
|
| Enzo |
ALX-155-017-PC05 |
ET A receptor antagonist [FR 139317]
|
0.5mg* |
|
|
| Enzo |
ALX-155-018-MC05 |
ET B receptor antagonist [RES-701-1]
|
0.5mg |
|
|
| Enzo |
ALX-155-017-P001 |
ET A receptor antagonist [FR 139317]
|
1mg* |
|
|
| Enzo |
ALX-155-012-P001 |
ET A receptor antagonist [JKC-301]
|
1mg* |
|
|
| Enzo |
ALX-155-016-P001 |
ET receptor antagonist [PD 145,065]
|
1mg* |
|
|
| Enzo |
ALX-155-016-PC05 |
ET receptor antagonist [PD 145,065]
|
0.5mg* |
|
|
| Enzo |
ALX-155-012-PC05 |
ET A receptor antagonist [JKC-301]
|
0.5mg* |
|
|
| Enzo |
ALX-155-011-P001 |
ET A receptor antagonist [BQ-610]
|
1mg* |
|
|
| Enzo |
ALX-155-008-PC05 |
ET receptor antagonist [PD 142,893]
|
0.5mg* |
|
|
| Enzo |
ALX-155-008-P001 |
ET receptor antagonist [PD 142,893]
|
1mg* |
|
|